Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about treatment/resistant depression Recent news which mentions treatment/resistant depression First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression April 26, 2024 Tickers NEWS Tags Rob Conley Beckley Psytech Ltd News From Benzinga Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression March 28, 2024 Tickers ATAI NEWS Tags ATAI News Market News From Benzinga Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment February 29, 2024 Tickers CMPS Tags Psychedelics Benzinga Biotech From Benzinga UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center November 15, 2023 Tickers AWKNF CMPS Tags Penny Stocks News Markets From Benzinga Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation October 03, 2023 Tickers ATAI Tags Psychedelic/Assisted Therapies Management DMT Clinical Trial From Benzinga Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression September 06, 2023 Tickers CMPS Tags treatment/resistant depression Cannabis Market News From Benzinga GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026 August 24, 2023 Tickers GHRS Tags treatment/resistant depression Markets Market News From Benzinga Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies' July 18, 2023 Tickers CMPS Tags Cannabis Market News Markets From Benzinga COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital July 05, 2023 Tickers ATAI CMPS HTGC Tags Benzinga Psychedelics Psychedelics Financing From Benzinga Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD May 30, 2023 Tickers CMPS NUMIF Tags Psychedelic/Assisted Therapies CMPS Small Cap From Benzinga GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer May 11, 2023 Tickers GHRS Tags GHRS Earnings Guidance From Benzinga Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression May 04, 2023 Tags Psychedelics Benzinga Dr/ Rob Conley From Benzinga Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results January 12, 2023 Tickers ATAI CMPS IGXT Tags IGXT News ATAI From Benzinga Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far December 12, 2022 Tickers CMPS Tags treatment/resistant depression Market News Cannabis From Benzinga Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments December 09, 2022 Tickers CMPS Tags Management Legal Small Cap From Benzinga Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes November 16, 2022 Tickers CMPS Tags News treatment/resistant depression Cannabis From Benzinga Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders November 02, 2022 Tags Contracts treatment/resistant depression Catalent From Benzinga atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing October 05, 2022 Tickers ATAI Tags Small Cap treatment/resistant depression Markets From Benzinga Psilocybin For Anorexia: Learn About Compass' Novel Phase 2 Trial Using Magic Mushroom's Main Compound July 28, 2022 Tickers CMPS Tags News Columbia University Irving Medical School COMPASS Pathways PLC From Benzinga Psilocybin More Effective Than Antidepressants In Treating Depression, New Study Shows April 12, 2022 Tags Psychology News treatment/resistant depression From Benzinga COMPASS Pathways: Positive Psilocybin Trial, High-Dose Group Improves Beyond Depression Reduction December 01, 2021 Tickers CMPS Tags Positive and Negative Affect Schedule Peter Thiel CMPS From Benzinga Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying November 16, 2021 Tickers GHRS Tags Benzinga Small Business Sonoran desert toad From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.